Skip to main content
Top
Gepubliceerd in: Quality of Life Research 1/2011

01-02-2011

Solitary pulmonary nodules: consequences for patient quality of life

Auteurs: Irawati Lemonnier, Cédric Baumann, Damien Jolly, Patrick Arveux, Marie-Christine Woronoff-Lemsi, Michel Velten, Francis Guillemin

Gepubliceerd in: Quality of Life Research | Uitgave 1/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The aim was to describe levels of health-related quality of life (HRQoL) and its determinants in patients with solitary pulmonary nodule (SPN) and to compare them with the French general population.

Methods

A prospective multicentre study of patients diagnosed with SPN, in northeastern regions of France, was carried out between 2002 and 2005. Six months after the end of diagnostic procedure, patients completed the SF-36 self-reported questionnaire (where 100 indicates high HRQoL). For a comparison, HRQoL data from a sample of the French general population collected by INSEE in 2002–2003 (n = 17,750).

Results

Among 171 participating patients, 39 had malignant nodules and had lesser mean scores on physical and emotional role, vitality and social functioning (6 to18 points) than those with nonmalignant nodule. Compared to the French general population, patients with SPN had lower scores, by 11–30 points, in all dimensions (P < 0.001). Older age and smoking history were associated with low HRQoL.

Conclusions

Six months after receiving a diagnosis of SPNs, whether malignant, patients have worse HRQoL compared to the French general population. It indicates areas where physicians can help patients coping with their disease.
Literatuur
1.
go back to reference Beigelman-Aubry, C., Hill, C., & Grenier, P. A. (2007). Management of an incidentally discovered pulmonary nodule. European Radiology, 17, 449–466.CrossRefPubMed Beigelman-Aubry, C., Hill, C., & Grenier, P. A. (2007). Management of an incidentally discovered pulmonary nodule. European Radiology, 17, 449–466.CrossRefPubMed
2.
go back to reference Ost, D., & Fein, A. (2004). Management strategies for the solitary pulmonary nodule. Current Opinion in Pulmonary Medicine, 10(4), 272–278.CrossRefPubMed Ost, D., & Fein, A. (2004). Management strategies for the solitary pulmonary nodule. Current Opinion in Pulmonary Medicine, 10(4), 272–278.CrossRefPubMed
3.
go back to reference Lillington, G. A. (1991). Management of solitary pulmonary nodules. Disease-a-Month, 37(5), 271–318.CrossRefPubMed Lillington, G. A. (1991). Management of solitary pulmonary nodules. Disease-a-Month, 37(5), 271–318.CrossRefPubMed
4.
go back to reference Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001). Cancer statistics, 2001. CA: A Cancer Journal for Clinicians, 51(1), 15–36.CrossRef Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001). Cancer statistics, 2001. CA: A Cancer Journal for Clinicians, 51(1), 15–36.CrossRef
5.
go back to reference Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002). Cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 52(1), 23–47.CrossRef Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002). Cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 52(1), 23–47.CrossRef
6.
go back to reference Swanson, S. J., Jaklitsch, M. T., Mentzer, S. J., Bueno, R., Lukanich, J. M., & Sugarbaker, D. J. (1999). Management of the solitary pulmonary nodule: Role of thoracoscopy in diagnosis and therapy. Chest, 116(6 Suppl), 523S–524S.CrossRefPubMed Swanson, S. J., Jaklitsch, M. T., Mentzer, S. J., Bueno, R., Lukanich, J. M., & Sugarbaker, D. J. (1999). Management of the solitary pulmonary nodule: Role of thoracoscopy in diagnosis and therapy. Chest, 116(6 Suppl), 523S–524S.CrossRefPubMed
7.
go back to reference Alzahouri, K., Velten, M., Arveux, P., Woronoff-Lemsi, M. C., Jolly, D., & Guillemin, F. (2008). Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: A multicentre study in 18 French districts. BMC Cancer, 8, 93.CrossRefPubMed Alzahouri, K., Velten, M., Arveux, P., Woronoff-Lemsi, M. C., Jolly, D., & Guillemin, F. (2008). Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: A multicentre study in 18 French districts. BMC Cancer, 8, 93.CrossRefPubMed
8.
go back to reference Lillington, G. A. (1997). Management of solitary pulmonary nodules. How to decide when resection is required. Postgraduate Medicine, 101(3), 145–150. Lillington, G. A. (1997). Management of solitary pulmonary nodules. How to decide when resection is required. Postgraduate Medicine, 101(3), 145–150.
9.
go back to reference Trunk, G., Gracey, D. R., & Byrd, R. B. (1974). The management and evaluation of the solitary pulmonary nodule. Chest, 66(3), 236–239.CrossRefPubMed Trunk, G., Gracey, D. R., & Byrd, R. B. (1974). The management and evaluation of the solitary pulmonary nodule. Chest, 66(3), 236–239.CrossRefPubMed
10.
go back to reference Beijer, S., Kempen, G. I., Pijls-Johannesma, M. C., de Graeff, A., & Dagnelie, P. C. (2008). Determinants of overall quality of life in preterminal cancer patients. International Journal of Cancer, 123(1), 232–235.CrossRef Beijer, S., Kempen, G. I., Pijls-Johannesma, M. C., de Graeff, A., & Dagnelie, P. C. (2008). Determinants of overall quality of life in preterminal cancer patients. International Journal of Cancer, 123(1), 232–235.CrossRef
11.
go back to reference Lheureux, M., Raherison, C., Vernejoux, J. M., Nguyen, L., Nocent, C., Tunon De Lara, M., et al. (2004). Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? Lung Cancer, 43, 175–182.CrossRefPubMed Lheureux, M., Raherison, C., Vernejoux, J. M., Nguyen, L., Nocent, C., Tunon De Lara, M., et al. (2004). Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? Lung Cancer, 43, 175–182.CrossRefPubMed
12.
go back to reference Montazeri, A., Gillis, C. R., & McEwen, J. (1998). Quality of life in patients with lung cancer: A review of literature from 1970 to 1995. Chest, 113(2), 467–481.CrossRefPubMed Montazeri, A., Gillis, C. R., & McEwen, J. (1998). Quality of life in patients with lung cancer: A review of literature from 1970 to 1995. Chest, 113(2), 467–481.CrossRefPubMed
13.
go back to reference Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2003). How quality of life data contribute to our understanding of cancer patients’ experiences? A study of patients with lung cancer. Quality of Life Research, 12(2), 157–166.CrossRefPubMed Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2003). How quality of life data contribute to our understanding of cancer patients’ experiences? A study of patients with lung cancer. Quality of Life Research, 12(2), 157–166.CrossRefPubMed
14.
go back to reference Efficace, F., Bottomley, A., Smit, E. F., Lianes, P., Legrand, C., Debruyne, C., et al. (2006). Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Annals of Oncology, 17(11), 1698–1704.CrossRefPubMed Efficace, F., Bottomley, A., Smit, E. F., Lianes, P., Legrand, C., Debruyne, C., et al. (2006). Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Annals of Oncology, 17(11), 1698–1704.CrossRefPubMed
15.
go back to reference Langendijk, H., Aaronson, N. K., de Jong, J. M., ten Velde, G. P., Muller, M. J., & Wouters, M. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy & Oncology, 55(1), 19–25.CrossRef Langendijk, H., Aaronson, N. K., de Jong, J. M., ten Velde, G. P., Muller, M. J., & Wouters, M. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy & Oncology, 55(1), 19–25.CrossRef
16.
go back to reference Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2001). Quality of life in lung cancer patients: As an important prognostic factor. Lung Cancer, 31(2–3), 233–240.CrossRefPubMed Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2001). Quality of life in lung cancer patients: As an important prognostic factor. Lung Cancer, 31(2–3), 233–240.CrossRefPubMed
17.
go back to reference Testa, M. A., & Simonson, D. C. (1996). Assesment of quality-of-life outcomes. The New England Journal of Medicine, 334(13), 835–840.CrossRefPubMed Testa, M. A., & Simonson, D. C. (1996). Assesment of quality-of-life outcomes. The New England Journal of Medicine, 334(13), 835–840.CrossRefPubMed
18.
go back to reference van Gerth, R. W. (2005). Assessment of quality of life: Adavantages and pitfals. Journal of Clinical and Experimental All Review, 5, 32–35.CrossRef van Gerth, R. W. (2005). Assessment of quality of life: Adavantages and pitfals. Journal of Clinical and Experimental All Review, 5, 32–35.CrossRef
19.
go back to reference The WHOQOL Group. (1993). Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153–159.CrossRef The WHOQOL Group. (1993). Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153–159.CrossRef
20.
go back to reference Brédart, A., & Dolbeault, S. (2005). Quality of life assessment in oncology: I. Definitions and objectives. Review of Francopoh Psycho-Oncologie, 1, 7–11.CrossRef Brédart, A., & Dolbeault, S. (2005). Quality of life assessment in oncology: I. Definitions and objectives. Review of Francopoh Psycho-Oncologie, 1, 7–11.CrossRef
21.
go back to reference Lemonnier, I., Baumann, C., Jay, N., Alzahouri, K., Arveux, P., Jolly, D., et al. (2009). Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France. BMC Cancer, 9, 139.CrossRefPubMed Lemonnier, I., Baumann, C., Jay, N., Alzahouri, K., Arveux, P., Jolly, D., et al. (2009). Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France. BMC Cancer, 9, 139.CrossRefPubMed
22.
go back to reference L’INSEE. (2007). La France en faits et chiffres: Estimations de population au 1er janvier. L’INSEE. L’INSEE. (2007). La France en faits et chiffres: Estimations de population au 1er janvier. L’INSEE.
23.
go back to reference INSEE. (2008). L’Enquete de Santé 2002–2003. INSEE. INSEE. (2008). L’Enquete de Santé 2002–2003. INSEE.
24.
go back to reference Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T., et al. (1992). Validating the SF-36 health survey questionnaire: New outcome measure for primary care. British Medical Journal, 305(6846), 160–164.CrossRefPubMed Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T., et al. (1992). Validating the SF-36 health survey questionnaire: New outcome measure for primary care. British Medical Journal, 305(6846), 160–164.CrossRefPubMed
25.
go back to reference Ware, J. J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–783.CrossRefPubMed Ware, J. J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–783.CrossRefPubMed
26.
go back to reference Frost, M. H., Bonomi, A. E., Ferrans, C. E., Wong, G. Y., & Hays, R. D. (2002). Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings, 77(5), 488–494.CrossRefPubMed Frost, M. H., Bonomi, A. E., Ferrans, C. E., Wong, G. Y., & Hays, R. D. (2002). Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings, 77(5), 488–494.CrossRefPubMed
27.
go back to reference Brunelli, A., Socci, L., Refai, M., Salati, M., Xiume, F., & Sabbatini, A. (2007). Quality of life before and after major lung resection for lung cancer: A prospective follow-up analysis. The Annals of Thoracic Surgery, 84(2), 410–416.CrossRefPubMed Brunelli, A., Socci, L., Refai, M., Salati, M., Xiume, F., & Sabbatini, A. (2007). Quality of life before and after major lung resection for lung cancer: A prospective follow-up analysis. The Annals of Thoracic Surgery, 84(2), 410–416.CrossRefPubMed
28.
go back to reference Handy, J. R., Jr., Asaph, J. W., Skokan, L., Reed, C. E., Koh, S., Brooks, G., et al. (2002). What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest, 122(1), 21–30.CrossRefPubMed Handy, J. R., Jr., Asaph, J. W., Skokan, L., Reed, C. E., Koh, S., Brooks, G., et al. (2002). What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest, 122(1), 21–30.CrossRefPubMed
29.
go back to reference Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13(2), 283–298.CrossRefPubMed Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13(2), 283–298.CrossRefPubMed
30.
go back to reference Lababede, O., Meziane, M. A., & Rice, T. W. (1999). TNM staging of lung cancer: A quick reference chart. Chest, 115(1), 233–235.CrossRefPubMed Lababede, O., Meziane, M. A., & Rice, T. W. (1999). TNM staging of lung cancer: A quick reference chart. Chest, 115(1), 233–235.CrossRefPubMed
31.
go back to reference Perrotin, C., Lemeunier, P., Grahek, D., Molina, T., Petino, A., Alifano, M., et al. (2005). Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors. Revue des Maladies Respiratoires, 22(4), 579–585.PubMed Perrotin, C., Lemeunier, P., Grahek, D., Molina, T., Petino, A., Alifano, M., et al. (2005). Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors. Revue des Maladies Respiratoires, 22(4), 579–585.PubMed
32.
go back to reference Schiller, J. H. (2001). Current standards of care in small-cell and non-small-cell lung cancer. Oncology, 61(Suppl 1), 3–13.CrossRefPubMed Schiller, J. H. (2001). Current standards of care in small-cell and non-small-cell lung cancer. Oncology, 61(Suppl 1), 3–13.CrossRefPubMed
33.
go back to reference King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555–567.CrossRefPubMed King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555–567.CrossRefPubMed
34.
go back to reference Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56(5), 395–407.CrossRefPubMed Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56(5), 395–407.CrossRefPubMed
35.
go back to reference Cooper, J. D. (2002). Management of the solitary pulmonary nodule: Directed resection. Seminars in Thoracic and Cardiovascular Surgery, 14(3), 286–291.PubMed Cooper, J. D. (2002). Management of the solitary pulmonary nodule: Directed resection. Seminars in Thoracic and Cardiovascular Surgery, 14(3), 286–291.PubMed
36.
go back to reference Lejeune, C., Al Zahouri, K., Woronoff-Lemsi, M. C., Arveux, P., Bernard, A., Binquet, C., et al. (2005). Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule. The European Journal of Health Economics, 6(3), 203–214.CrossRefPubMed Lejeune, C., Al Zahouri, K., Woronoff-Lemsi, M. C., Arveux, P., Bernard, A., Binquet, C., et al. (2005). Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule. The European Journal of Health Economics, 6(3), 203–214.CrossRefPubMed
37.
go back to reference Tan, B. B., Flaherty, K. R., Kazerooni, E. A., & Iannettoni, M. D. (2003). The solitary pulmonary nodule. Chest, 123(1 Suppl), 89S–96S.CrossRefPubMed Tan, B. B., Flaherty, K. R., Kazerooni, E. A., & Iannettoni, M. D. (2003). The solitary pulmonary nodule. Chest, 123(1 Suppl), 89S–96S.CrossRefPubMed
Metagegevens
Titel
Solitary pulmonary nodules: consequences for patient quality of life
Auteurs
Irawati Lemonnier
Cédric Baumann
Damien Jolly
Patrick Arveux
Marie-Christine Woronoff-Lemsi
Michel Velten
Francis Guillemin
Publicatiedatum
01-02-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 1/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9719-0

Andere artikelen Uitgave 1/2011

Quality of Life Research 1/2011 Naar de uitgave